Novo Nordisk’s Ozempic gains USFDA approves to cut risk of diabetic kidney disease progression Read more
Lupin gains USFDA approval for Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension Read more
USFDA lifts clinical hold on Opella’s planned actual use trial to switch Cialis from prescription to OTC Read more
Alembic Pharma gets USFDA final approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg Read more
Lupin launches Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous Bisglycinate Tablets) in the US Read more
